Health X Platform
Ticker > Company >

Health X Platform share price

Health X Platform Ltd.

NSE: HEALTHX BSE: 533259 SECTOR: Finance - NBFC  41.93 K   47   4

285.00
+7.15 (2.57%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 287.9

Today's Low

₹ 270

52 Week High

₹ 375

52 Week Low

₹ 241.5

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 906.6 Cr.

Advances

₹ 4.31 Cr.

No. of Shares

3.18 Cr.

P/E

0

P/B

3.35

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  85.19

Operating Revenue

₹ 0.4 Cr.

Net Profit

₹ -0.71 Cr.

Promoter Holding

74.84 %

EPS (TTM)

₹  -0.27

Sales Growth

0

ROE

-0.26 %

ROCE

-0.25%

Profit Growth

20.07 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Income Growth

1 Year16060%
3 Year∞%
5 Year110.82%

Profit Growth

1 Year20.07%
3 Year-44.35%
5 Year-202.34%

ROE%

1 Year-0.26%
3 Year-0.12%
5 Year-0.11%

ROCE %

1 Year-0.25%
3 Year-0.1%
5 Year-0.09%

ROA%

-0.2619

PEG Ratio

NA

PAT Margin (%)

-176.6584

EPS Growth(%)

20.057

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2026 74.84 0.00
Dec 2025 74.69 0.00
Sep 2025 74.24 0.00
Jun 2025 74.24 0.00
Mar 2025 74.11 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Promoters shareholding is 74.84%.

 Limitations

  • Company has a poor Return on Equity (ROE) track record of -0.117133333333333%.
  • The company a poor ROCE track record of -0.104233333333333% since last 3 years.
  • The company has delivered poor profit growth of 0% over past 3 years

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Operating Revenue 0.11 0.1 0.1 0.1 0.1
Other Income 0.19 0.2 0.26 0.01 0.01
Interest Expended 0 0 0.06 0 0
Operating Expenses 0.38 0.34 0.38 0.37 0.49
Total Provisions 0 0 0 0 0
Depreciation 0.02 0.03 0.02 0.02 0.03
Profit Before Tax -0.11 -0.07 -0.11 -0.28 -0.41
Tax 0 0 0 0 0
Net Profit -0.1 -0.07 -0.11 -0.28 -0.41
Adjusted EPS (RS) -0.03 -0.02 -0.03 -0.09 -0.13

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Operating Income 0 0 0 0 0.4
Other Income 0.96 0.92 2.25 1.18 0.8
Interest 0.03 0.03 0.03 0.04 0.03
Operating Expenses 1.05 1.2 1.47 2.01 1.87
Total Provisions 0.02 0.02 0.1 0.02 0.02
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.14 -0.34 0.65 -0.89 -0.71
Tax 0 0.05 0 0 0
Profit After Tax -0.14 -0.39 0.65 -0.89 -0.71
Adjusted EPS (Rs.) -0.04 -0.12 0.2 -0.28 -0.22

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 31.81 31.81 31.81 31.81 31.81
Total Reserves 241.44 241 241.61 240.72 239.99
Borrowings 0 0 0 0 0
Other N/C liabilities 0 0 0 0.15 0.15
Current liabilities 0.27 0.3 0.43 0.24 0.2
Total Liabilities 273.52 273.11 273.85 272.93 272.16
Assets
Loans 0 0 0 0 4.31
Net Block 3.24 3.12 2.13 2.02 1.94
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 264.6 264.6 264.6 264.6 264.6
Other Loans 0.11 4.1 5.02 0.25 0.26
Other N/C Assets 0 0 0 0.04 0.09
Current Assets 5.57 1.29 2.11 6.01 0.97
Total Assets 273.52 273.11 273.85 272.93 272.16
* Other Non-current Liabilities include Net deferred Liabilities

Corporate Actions

Investors Details

PARTICULARS Mar 2025% Jun 2025% Sep 2025% Dec 2025% Mar 2026%
promoters 74.11 74.24 74.24 74.69 74.84
abha mittal 0.05 0.05 0.05 0.05 0.05
banwari lal mittal 33.37 33.37 33.37 33.76 33.91
bharati sharma 1.02 1.02 1.02 1.02 1.02
luv kush projects limited... 11.78 11.90 11.90 11.96 11.96
ravi kant sharma 3.14 3.14 3.14 3.14 3.14
topview enclaves llp 24.76 24.76 24.76 24.76 24.76
PARTICULARS Mar 2025% Jun 2025% Sep 2025% Dec 2025% Mar 2026%
investors 25.89 25.76 25.76 25.31 25.16
airavat capital trust - a... - - 1.14 1.14 1.23
investor education and pr... - 0.05 - 0.05 0.44
legends global opportunit... - - - - 1.02
lekh raj juneja 1.89 1.89 1.89 1.89 1.89
llp 0.53 0.57 0.69 0.70 0.67
magnum health and safety ... 1.73 1.73 1.73 1.53 1.44
sanjay agarwal, rahul kum... 1.28 1.28 1.28 1.28 1.28
k2j capital llc - - - 1.10 -
airavat capital trust 1.12 1.14 - - -
investor education and pr... 0.05 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q3FY24
Concall Q2FY25
Concall Q2FY24
Concall Q1FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY24
Presentation Q3FY23
Presentation Q3FY23
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY24
Presentation Q2FY23
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY24
Presentation Q1FY23

Company News

Sastasundar Ventures informs about updates 24 Apr, 5:24 PM Sastasundar Ventures informs about disclosure 13 Mar, 4:24 PM Sastasundar Ventures informs about earnings call transcript 16 Feb, 2:48 PM Sastasundar Ventures informs about newspaper publication 7 Feb, 3:47 PM Sastasundar Ventures - Quaterly Results 7 Feb, 12:00 AM Sastasundar Ventures informs about earnings conference call 2 Feb, 3:11 PM Sastasundar Ventures informs about compliances-certificate 14 Jan, 4:15 PM Sastasundar Ventures informs about disclosure 29 Nov, 10:32 AM Sastasundar Ventures submits BRSR 2 Sep, 5:31 PM Sastasundar Ventures - Quaterly Results 12 Aug, 6:53 PM Sastasundar Ventures - Quaterly Results 12 Aug, 6:53 PM Sastasundar Ventures informs about newspaper publication 18 Jul, 3:11 PM Sastasundar Ventures informs about analyst meet 9 Jun, 1:02 PM Sastasundar Ventures informs about completion of transaction for sale of stake of step-down subsidiary 31 May, 11:02 AM Sastasundar Ventures - Quaterly Results 30 May, 9:53 PM Sastasundar Ventures informs about disclosure 3 Apr, 10:01 AM Sastasundar Ventures informs about investor presentation 19 Feb, 4:44 PM Sastasundar Ventures - Quaterly Results 14 Feb, 7:15 PM Sastasundar Ventures - Quaterly Results 14 Feb, 7:15 PM Sastasundar Ventures informs about investors meet 30 Nov, 3:28 PM Sastasundar Ventures informs about transcript of conference call 25 Nov, 5:28 PM Sastasundar Ventures informs about disclosure 23 Nov, 11:17 AM Sastasundar Ventures informs about press release 15 Nov, 1:00 PM Sastasundar Ventures informs about disclosure 9 Sep, 5:07 PM Sastasundar Ventures informs about newspaper advertisements 3 Sep, 5:26 PM Sastasundar Ventures - Quaterly Results 29 Jul, 6:34 PM Sastasundar Ventures - Quaterly Results 29 Jul, 6:34 PM Sastasundar Ventures’ arm incorporates wholly owned subsidiary 19 Jul, 9:58 AM Sastasundar Venture informs about investor presentation 10 Jun, 5:15 PM Sastasundar Ventures informs about newspaper publication 1 Jun, 4:04 PM Sastasundar Ventures - Quaterly Results 30 May, 8:46 PM Sastasundar Ventures - Quaterly Results 30 May, 8:46 PM Sastasundar Ventures informs about compliance certificate 22 Apr, 4:09 PM Sastasundar Ventures informs about outcome of board meeting 31 Jan, 4:39 PM Sastasundar Ventures - Quaterly Results 31 Jan, 4:30 PM Sastasundar Ventures - Quaterly Results 31 Jan, 4:30 PM Sastasundar Ventures - Quaterly Results 31 Jan, 4:30 PM Sastasundar Ventures - Quaterly Results 10 Nov, 4:53 PM Sastasundar Ventures - Quaterly Results 10 Nov, 4:53 PM Sastasundar Ventures submits annual report 6 Sep, 4:30 PM Sastasundar Ventures - Quaterly Results 11 Aug, 4:56 PM Sastasundar Ventures - Quaterly Results 11 Aug, 4:56 PM Sastasundar Ventures - Quaterly Results 14 Jul, 5:38 PM Sastasundar Ventures - Quaterly Results 14 Jul, 5:38 PM Sastasundar Ventures - Quaterly Results 14 Feb, 3:42 PM Sastasundar Ventures - Quaterly Results 14 Feb, 3:42 PM Sastasundar Ventures - Quaterly Results 14 Feb, 3:42 PM Sastasundar Ventures informs about closure of trading window 30 Dec, 4:22 PM Sastasundar Ventures - Quaterly Results 14 Nov, 5:36 PM Sastasundar Ventures - Quaterly Results 14 Nov, 5:36 PM

Health X Platform Stock Price Analysis and Quick Research Report. Is Health X Platform an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Health X Platform. 

Key Financials -

  • Profitability: Profit margin (PAT margin) of the company shows how well a company controls its cost. It is one of the important indicators to show the financial health of the company. Net profit of Health X Platform is Rs -0.7137 Cr. and the compounded growth of profit in the past 3 years is -44.3497370559506%. The PAT margin of Health X Platform is -176.6584%.
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Health X Platform , the EPS grew by 20.057% YOY. 

 Financial Ratios -

  • Return on Equity (ROE): Health X Platform has a poor ROE track record. The ROE of Health X Platform is at -0.2622% for the latest year.
  • P/E Ratio: Relative valuation metrics like the P/E ratio can be used to see if the stock of Health X Platform is worth at the current levels at Rs 279.15. Health X Platform is trading at a current P/E ratio of 0 and the average historical P/E for the last 5 years was 215.56534.
  • P/B ratio can be one of the best metrics to value such companies. Currently, Health X Platform is trading at a P/B of 3.27675843311903. The average historical P/B for the last 5 years was 2.89064562636867. This can be compared with the Market price per share in order to know if the stock is undervalued or overvalued.

One can find all the Financial Ratios of Health X Platform in Ticker for free. Also, one can get the intrinsic value of Health X Platform by using Valuation Calculators, which are available with a Finology ONE subscription. 

Health X Platform FAQs

Q1. What is Health X Platform share price today?
Ans: The current share price of Health X Platform is Rs 279.15.

Q2. What is the market capitalisation of Health X Platform?
Ans: Health X Platform has a market capitalisation of Rs 887.9901075 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Health X Platform?
Ans: The PE ratio of Health X Platform is -1025.53269654666 and the P/B ratio of Health X Platform is 3.27675843311903, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Health X Platform share?
Ans: The 52-week high share price of Health X Platform is Rs 363, and the 52-week low share price of Health X Platform is Rs 241.6.

Q5. Does Health X Platform pay dividends?
Ans: Currently, Health X Platform does not pay dividends. Dividend yield of Health X Platform is around 0%.

Q6. What are the face value and book value of Health X Platform shares?
Ans: The face value of Health X Platform shares is Rs 10, while the book value per share of Health X Platform is around Rs 85.1909. Face value is the nominal value set by the company, whereas book value reflects its accounting worth. 

Q7. What are the ROE and ROCE of Health X Platform?
Ans: The ROE of Health X Platform is -0.2622% and ROCE of Health X Platform is -0.25%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q8. Is Health X Platform a good buy for the long term?
Ans: The Health X Platform long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q9. Is Health X Platform undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Health X Platform appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q10. How to check Health X Platform’s financials?
Ans: You can review Health X Platform’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Health X Platform
X